[1] Quang KT,Do HT,Hung VP,et al. Study on the co-infection of children with severe community-acquired pneumonia[J]. Pediatr Int,2022,64:e14853. doi: 10.1111/ped.14853. [2] Lv YT,Sun XJ,Chen Y,et al. Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020[J]. Ann Transl Med,2022,10:1123. doi: 10.21037/atm-22-4304. [3] Zhang C,Zhang Q, Du JL,et al. Correlation between the clinical severity, bacterial load, and inflammatory reaction in children with Mycoplasma pneumoniae pneumonia[J]. Curr Med Sci,2020,40:822-828. doi: 10.1007/s11596-020-2261-6. [4] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30:1304-1308. doi:10.3760/cma.j.issn.2095-428X.2015.17.006. [5] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51:745-752. doi:10.3760/cma.j.issn.0578-1310.2013.11.012. [6] He WY,Yin JS,Wan Y. Correlations of different serological parameters with the severity and prognosis of pneumonia in children infected with Mycoplasma pneumoniae[J]. Clin Lab,2022,68:211132. doi: 10.7754/Clin.Lab.2022.211132. [7] 管峥,霍洁,袁晶,等.血清乳酸脱氢酶联合白细胞介素18对儿童难治性肺炎支原体肺炎的预测作用[J].实用医学杂志,2020,36:2848-2851. doi: 10.3969/j.issn.1006-5725.2020.20.021. [8] 陈方,陈全景.血清乳酸脱氢酶同工酶对儿童难治性肺炎支原体肺炎的诊断价值[J].中国医师进修杂志,2019,42:634-638. [9] Huang KL,Liu JH,Lv WS,et al. Analysis of risk factors of bronchiolitis obliterans in children with Mycoplasma pneumoniae bronchiolitis[J]. Comput Math Methods Med,2022,1: 9371406. doi: 10.1155/2022/9371406. [10] Choi YJ,Jeon JH,Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study[J]. Respir Res,2019,20:193. doi: 10.1186/s12931-019-1152-5. [11] Xu H,Feng GS,Cai SY,et al. Predictive model for discrimination of tuberculous pleural effusion from severe Mycoplasma pneumoniae pneumonic effusion in children[J]. Pediatr Infect Dis J,2019,38:1100-1103. doi: 10.1097/INF.0000000000002438. |